pAAV-U6-sgRNA (LSL targeting)-CMV-ps2-CasMINI
(Plasmid
#261716)
-
PurposeloxP-STOP-loxP (LSL) gene editing using ps2-CasMINI
-
Depositing Lab
-
Depositing OrganizationStanford University
Located in the United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 261716 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepAAV
-
Vector typeAAV, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameU6-sgRNA (LSL targeting)-CMV-ps2-CasMINI
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-U6-sgRNA (LSL targeting)-CMV-ps2-CasMINI was a gift from Michael Lin (Addgene plasmid # 261716 ; http://n2t.net/addgene:261716 ; RRID:Addgene_261716) -
For your References section:
Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound. Song D, Malinao MG, Wu X, Jiang S, Jiang D, Westberg M, Su Y, Cai S, Lee D, Repina NA, Schaffer DV, Ji HP, Hong G, Lin MZ. Cell. 2026 Sep 28:S0092-8674(26)01074-3. doi: 10.1016/j.cell.2026.09.005. 10.1016/j.cell.2026.09.005 PubMed 42805175